Genes and Signal Transduction in Multistage Carcinogenesis
eBook - ePub

Genes and Signal Transduction in Multistage Carcinogenesis

  1. 480 pages
  2. English
  3. ePUB (mobile friendly)
  4. Available on iOS & Android
eBook - ePub

Genes and Signal Transduction in Multistage Carcinogenesis

About this book

This book describes the identification and characterization of genetic loci that determine susceptibility to liver, mammary, or skin carcinogenesis in rodents. It focuses on protein kinases and phospholipases, and stress-related signal transduction.

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
At the moment all of our mobile-responsive ePub books are available to download via the app. Most of our PDFs are also available to download and we're working on making the final remaining ones downloadable now. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, weโ€™ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere โ€” even offline. Perfect for commutes or when youโ€™re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Genes and Signal Transduction in Multistage Carcinogenesis by Nancy H. Colburn in PDF and/or ePUB format, as well as other popular books in Medicine & Genetics in Medicine. We have over one million books available in our catalogue for you to explore.

Information

Publisher
CRC Press
Year
2020
Print ISBN
9780824779962

I GENETIC VARIANTS FOR RESPONSES TO CARCINOGENS, TUMOR PROMOTERS, AND GROWTH FACTORS

1 Genetic Control of Hepatocarcinogenesis in Inbred Mice

Norman R. Drinkwater
University of Wisconsin-Madison, Madison, Wisconsin

INTRODUCTION

Studies of skin tumor induction in mice have allowed the division of carcinogenesis into two experimentally distinguishable stages, initiation and promotion [1], With these observations as a paradigm, two-stage carcinogenesis also has been described for the liver [2] and other tissues [3].
Initiation of carcinogenesis is widely thought to result from the induction of a mutation in the target cell [4]. Recent studies of tumor induction in breast [5,6,], skin [7], and liver [8-10] in rats or mice have implicated at least one family of genes, the ras cellular proto-oncogenes, as targets for initiation of carcinogenesis. A large proportion of chemically induced tumors of these tissues contained mutant c-ras genes capable of transforming NIH3T3 cells after transfection of tumor deoxyribonucleic acid (DNA). It is likely that the induction of these mutations represents initiating events because the DNA sequence changes that resulted in the transforming activity of the mutant genes depended on the chemicals used to induce the tumors [5,6,10].
In contrast to the essentially instantaneous nature of initiation in the target cell, the promotion stage of carcinogenesis represents over time a composite of events involving alterations in the expression of specific genes, proliferation of the initiated cell and its clonal descendants, and the accumulation of additional genetic alterations [11]. Studies of the interaction of specific tumor promoters with cellular components have yielded a powerful biochemical approach to characterizing these events. For example, the identification of protein kinase C as the receptor for the phorbol esters has provided a molecular basis for the diverse activities of this family of tumor promoters [12].
A complementary genetic approach to understanding the complex process of promotion is the characterization of host genes that act as physiological modulators or targets for postinitiation events in carcinogenesis. These genes may be identified by their effects on the susceptibility of the animal to tumor induction. This chapter will describe studies of hepatocarcinogenesis in inbred mouse strains that demonstrate the existence of several polymorphic loci that control susceptibility to liver tumor induction. Also discussed is the characterization of a specific gene, identified through studies of the high susceptibility of C3H mice to hepatocarcinogenesis, that exerts its effect during liver tumor promotion.

VARIATION AMONG INBRED MOUSE STRAINS IN SUSCEPTIBILITY TO SPONTANEOUS AND INDUCED HEPATOCARCINOGENESIS

The earliest demonstration of genetic factors in the development of cancer was the observation of characteristic patterns of spontaneous tumor incidence among inbred mouse strains [13], Most of the common inbred mouse strains were developed between 1910 and 1930 by brother-sister mating of mice derived from various stocks obtained from dealers in the pet mouse trade [14]. In spite of the relatively small population sizes of the progenitor stocks and the common origins of many of the strains, the collection of inbred mouse strains demonstrates an extraordinary degree of genetic variation [15,16]. One measure of genetic diversity is heterozygosity; that is, the probability that an individual will carry two different alleles at a randomly chosen locus. Estimates of the degree of heterozygosity in wild mouse populations range between 0.07 and 0.11 [15,17]. In contrast, the estimated heterozygosity for a population of mice derived from equal numbers of mice from common inbred strains is 0.3-0.4 [15]. Thus, comparison of inbred mouse strains provides a reasonable starting point for the identification of polymorphic loci that influence the susceptibility of mice to hepatocarcinogenesis.
The lifetime liver tumor incidences for untreated male mice from selected inbred strains are summarized in Table 1. These data were obtained from several studies (see Table 1 for references) in which the animals were allowed to live out their natural lifespan under standard laboratory conditions. The data in the table are grouped by families of inbred strains in which the strains share to varying degrees common origins [14]. In addition to the incidence of liver tumors, the 90%-confidencc interval [24] has been calculated to allow comparisons between experiments involving widely differing numbers of animals. Data for liver tumor incidence in female mice are available from the same sources; the
Table Lifetime Spontaneous Incidences of Liver Tumors in Male Inbred Mice
Mouse strain Median survival (months) No. mice Incidence (%) Refs.
C57/C58 familya
C57BL/KaLwRij 24.0 232 5.0 (3.1,7.9)b 18
C57BL/10Sn 32.7 39 2.6 (0.6,5.9) 19
C57BL/6J 19.1 609 3.6 (2.5,5.1) 20
C57BR/cdJ 23.1 48 25 (16,36) 21
C58/J 12.3 51 0 (0,5.0) 21
DBA/Bagg albino family
CBA/BrRij 28.8 179 44 (38,50) 18
C3H/HeDiSn 21.9 61 51 (40,61) 19
DBA/2J 19.8 67 1.5 (0.3,6.5) 22
A/WySn 20.3 61 15 (8.8,24) 19
Balb/cStCrl 17.5 637 3.9 (2.8,5.4) 20
SM/J 18.8 64 0 (0,4.1) 21
101/129/LP family
129/J 29.4 54 0 (0,4.8) 22
LP/J 24.7 77 6.5 (3.2, 13) 22
Swiss family
RF/J 21.4 23 0 (0,11) 21
RFM/UnRij 19.8 326 0 (0,0.8) 18
SWR 23.9 269 1.1 (0.4,2.7) 23
New Zealand family
NZB/lac 18.0 153 2.0 (0.8,4.9) 18
a Mice are grouped as families of related strains according to [14].
b Values in parentheses are the lower and upper 90% confidence limits for the incidence of liver tumors.
frequency of liver tumors in female mice is generally lower than for male mice of the same strain and is appreciable (5-20%) only for the C3H and CBA strains [18,19,25].
Few studies of chemically induced hepatocarcinogenesis have compared many inbred mouse strains for their relative susceptibilities to tumor induction. In addition, comparisons between studies are hampered by the variety of agents and protocols used for inducing tumors. In order to provide a basis for comparison, the rank order for susceptibility of inbred strains to induced hepatocarcinogenesis is summarized in Table for several studies in which at least three strains
Table 2 Susceptibilities of Inbred Male Mice to Chemically Induced Hepatocarcinogenesis
Goodall and Lijinksy [26]
(N-nitrosohexamethyleneimine, p.o. for 8 weeks, adults)a
Male (range 10-53% incidence):
NZB/BIGd, NZC/BIGd #x003C; NZO/BIGd, NZY/BlGdb
Female (range 0-40% incidence):
NZY/BIGd #x003C; NZB/BIGd,NZC/BIGd, NZO/BIGd
Matsuyama and Suzuki [27]
(ethylcarbamate, four weekly s.c. injections, preweanling)
Male and Female range 12-91% incidence):
AKR/JMs, A/J, dd/I #x003C; SMA #x003C; C57BL/6Ms #x003C; CBA/H
Searle and Jones [28]
(N-ethyl-N-nitrosourea, single i.p. injection, newborn)
Male and Female (range 7-65% incidence):
IF/Bcr, A/Bcr #x003C; DBAf/Bcr #x003C; C57BL/Bcr
Flaks [29]
(7,1...

Table of contents

  1. Cover
  2. Half Title
  3. Title Page
  4. Copyright Page
  5. Preface
  6. Contents
  7. Contributors
  8. Part I Genetic Variants for Responses to Carcinogens, Tumor Promoters, and Growth Factors
  9. Part II Genes That Confer Susceptibility to Neoplastic Transformation
  10. Part III Signal Transduction: Protein Kinases and Phospholipases
  11. Part IV Stress-Associated Signals and Gene Regulation
  12. Index